Published Papers & Misc - Akihiro HIRAKAWA

Division display  181 - 200 of about 274 ／  All the affair displays >>

  1. Imai K, Kotani T, Tsuda H, Nakano T, Hirakawa A, Kikkawa F. A Novel Approach to Detecting Postpartum Hemorrhage Using Contrast-Enhanced Ultrasound Ultrasound in medicine and biology. 2017.03; 43 (3): 615-620.

  2. Hirakawa A, Kinoshita F. An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology. Therapeutic innovation & regulatory science. 2017.03; 51 (2): 207-211. ( PubMed, DOI )

  3. 谷垣 徹, 川瀬 世史明, 平川 晃弘, 岡本 修一, 大森 寛行, 平田 哲夫, 菊地 淳, 太田 秀彰, 三宅 泰次, 川村 一太, 大久保 宗則, 松尾 仁司. 計算による冠血流予備量比の診断性能の比較　三次元定量的冠動脈造影と冠動脈CT血管造影の比較(Comparison of Diagnostic Performance of Computed Fractional Flow Reserve: 3-Dimentional Quantitative Coronary Angiography versus Coronary Computed Tomography Angiography) 日本循環器学会学術集会抄録集. 2017.03; 81回 OJ-134. ( ichushi )

  4. Miyauchi R, Itoh Y, Kawamura M, Hirakawa A, Shibata K, Kajiyama H, Nakahara R, Kubota S, Ito J, Okada T, Kikkawa F, Naganawa S. Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer Nagoya Journal of Medical Science. 2017.02; 79 (2): 211-220.

  5. Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia Annals of Hematology. 2017.02; 96 (2): 289-297.

  6. Asano J, Hirakawa A (co-first author). Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: application to breast cancer data. Journal of Biopharmaceutical Statistics. 2017.02; 27 (6): 918-932.

  7. Gosho M, Maruo K, Tada K, Hirakawa A.. Utilization of chi-square statistics for screening adverse drug-drug interactions in spontaneous reporting systems. European Journal of Clinical Pharmacology. 2017.01; 73 (6): 779-786.

  8. Sawamura A, Okumura T, Hirakawa A, Ito M, Ozaki Y, Ohte N, Amano T, Murohara T; CHANGE PUMP Investigators. Early Prediction Model for Successful Bridge to Recovery in Patients With Fulminant Myocarditis Supported With Percutaneous Venoarterial Extracorporeal Membrane Oxygenation - Insights From the CHANGE PUMP Study Circulation Journal. 2017; 82 (3): 699-707.

  9. Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy PLoS One. 2016.12; 11 (12): e0168846.

  10. Fukui T, Fukumoto K, Okasaka T, Kawaguchi K, Nakamura S, Hakiri S, Ozeki N, Hirakawa A, Tateyama H, Yokoi K. Prognostic impact of tumour size in completely resected thymic epithelial tumours European Journal of Cardio-Thoracic Surgery. 2016.12; 50 (6): 1068-1074.

  11. Yamada S, Fujii T, Hirakawa A, Kanda M, Sugimoto H, Kodera Y. Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer Langenbeck's Archives of Surgery. 2016.12; 401 (8): 143-1152.

  12. Yonemori K, Hirakawa A (co-first author), Kawachi A, Kinoshita F, Ohkuma H, Nishikawa T, Kenji T, Fujiwara Y, Takebe N. . Drug induced Interstitial Lung Disease in Oncology Phase I Trials. Cancer Science. 2016.12; 107 (12): 1830-1836.

  13. Gosho M, Maruo K, Ishii R, Hirakawa A. Analysis of an incomplete longitudinal composite variable using a marginalized random effects model and multiple imputation. Statistical Methods in Medical Research. 2016.11; 27 (7): 2200-2215.

  14. Hirakawa A, Sato H, Gosho M.. Effect of design specifications in dose-finding trials for combination therapies in oncology. Pharmaceutical Statistics. 2016.11; 15 (6): 531-540.

  15. Sato H, Hirakawa A (co-first author), Hamada C. An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials. Statistics in Medicine. 2016.10; 35 (23): 4093-4109.

  16. Atsuta Y, Hirakawa A, Nakasone H, Kurosawa S, Oshima K, Sakai R, Ohashi K, Takahashi S, Mori T, Ozawa Y, Fukuda T, Kanamori H, Morishima Y, Kato K, Yabe H, Sakamaki H, Taniguchi S, Yamashita T. Late mortality and causes of death among long-term survivors after allogeneic stem cell transplantation Biology of Blood and Marrow Transplantation. 2016.09; 22 (9): 1702-1709.

  17. Harano K, Yonemori K, Hirakawa A. The influence of familial factors on the choice of the place of death for terminally ill breast cancer patients: a retrospective single-center study Breast Cancer. 2016.09; 23 (5): 797-806.

  18. Okuma H, Koizumi F, Hirakawa A, Nakatochi M, Komori O, Hashimoto J, Kodaira M, Yunokawa M, Yamamoto H, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies British Journal of Cancer. 2016.08; 115 (4): 411-419.

  19. Watanabe H, Atsuta N, Hirakawa A (co-first author), Nakamura R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, Watanabe H, Ito M, Katsuno M, Izumi Y, Morita M, Kanai K, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, Imai T, Kawata A, Aoki M, Tsuji S, Nakashima K, Kaji R, Sobue G. A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN Journal of Neurology, Neurosurgery, and Psychiatry. 2016.08; 87 (8): 851-858.

  20. Shimada K, Shimada S, Sugimoto K, Nakatochi M, Suguro M, Hirakawa A, Hocking TD, Takeuchi I, Tokunaga T, Takagi Y, Sakamoto A, Aoki T, Naoe T, Nakamura S, Hayakawa F, Seto M, Tomita A, Kiyoi H. Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma Leukemia. 2016.07; 30 (7): 1568-1579.

< PREV - NEXT >

To the head of this page.▲